Cns Pharmaceuticals Inc (NASDAQ:CNSP)’s traded shares stood at 2.49 million during the last session, with the company’s beta value hitting 1.12. At the close of trading, the stock’s price was $2.43, to imply an increase of 2.53% or $0.06 in intraday trading. The CNSP share’s 52-week high remains $1195.00, putting it -49076.95% down since that peak but still an impressive 7.82% since price per share fell to its 52-week low of $2.24.

Cns Pharmaceuticals Inc (NASDAQ:CNSP) trade information

After registering a 2.53% upside in the last session, Cns Pharmaceuticals Inc (CNSP) has traded red over the past five days. The 5-day price performance for the stock is -42.00%, and -51.25% over 30 days. With these gigs, the year-to-date price performance is -59.63%.

The extremes give us $0.5 and $0.5 for target low and target high price respectively. As such, CNSP has been trading 79.42% off suggested target high and 79.42% from its likely low.

CNSP Dividends

Cns Pharmaceuticals Inc has its next earnings report out in March. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.

Cns Pharmaceuticals Inc (NASDAQ:CNSP)’s Major holders

We also have Fidelity Extended Market Index Fund and Fidelity Series Total Market Index Fund as the top two Mutual Funds with the largest holdings of the Cns Pharmaceuticals Inc (CNSP) shares. Going by data provided on Dec 31, 2024, Fidelity Extended Market Index Fund holds roughly 6.87 shares. This is just over 0.01% of the total shares, with a market valuation of $16703.0. Data from the same date shows that the other fund manager holds a little less at 759.0, or 0.00% of the shares, all valued at about 1844.0.